Nivolumab in patients with advanced hepatocellular carcinoma (Checkmate 040): results of phase 1/2 dose escalation and expansion
El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, Kim T, Choo S, Trojan J, Welling TH, Meyer T, Kang Y, Yeo W, Chopra A, Anderson J, dela Cruz C, Lang L, Ne..., The Lancet, 1/1/2017Non-invasive liver ablation using histotripsy: preclinical safety study in an in vivo porcine model
Vlaisavljevich, E, Gabe O, Lundt M, Teofilovic D, Ives K, Duryea A, Bertolina J, Welling TH, Zhen X, Ultrasound Med Biol, 1/1/2017Individualized adaptive stereotactic body radiotherapy for liver tumors in patients at high risk for liver damage: A phase 2 clinical trial
Feng M, Suresh K, Schipper MJ, Bazzi L, Ben-Josef E, Matuszak MM, Parikh ND, Welling TH, Normolle D, Ten Haken RK, Lawrence TS, JAMA Oncol, 1/1/2017Comprehensive and integrative genomic characterization of hepatocellular carcinoma
The Cancer Genome Atlas Research Network, Cell, 1/1/2017Sensitivity of KRAS-mutant colorectal cancers to combination therapy that co-targets MEK and CDK4/6
Ziemke EK, Dosch JS, Maust JD, Shettigar A, Sen A, Welling TH, Hardiman KM, Sebolt-Leopold, JS, Clin Cancer Res, 1/1/2016Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, Wei S, Crespo J, Wan S, Vatan L, Szeliga W, Shao I, Wang Y, Liu Y, Varambally S, Chinnaiyan AM, Welling TH, Marquez VE, K..., Nat Immunol, 1/1/2016Non-invasive ultrasound liver ablation using histotripsy: chronic study in an in vivo rodent model
Vlaisavljevich E, Gail T, Gail M, Greve JM, Cheng X, Ives K, Shi J, Lifang J, Ara A, Hall T, Welling TH, Gabe O, Roberts W, Zhen X, Ultrasound Med Biol, 1/1/2016GM-CSF mediates mesenchymal-epithelial crosstalk in pancreatic cancer
Waghray M, Yalamanchili M, Dziubinski M, Zeinali M, Erkkinen M, Yang H, Schradle KA, Welling TH, Palmbos PL, Abel EV, Sahai V, Nagrath S, Wong L, Simeone DM, Cancer Discov, 1/1/2016Internal biliary stenting during orthotopic liver transplantation: anastomotic complications, post-transplant biliary interventions, and survival
Mathur AK, Nadig SN, Kingman S, Lee D, Kincade K, Sonnenday CJ, Welling TH, Clin Transpl, 1/1/2015Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomized, double-blind, placebo-controlled trial
Bruix J, Takayama T, Mazzaferro V, Chau GY, Yang J, Kudo M, Cai J, Poon RT, Han KH, Tak WY, Lee HC, Song T, Roayaie S, Bolondi L, Lee KS, Makuuchi M, Souza F, Berre MA..., Lancet Oncol, 1/1/2015Myeloid cells in hepatocellular carcinoma
Wan S, Kuo N, Kryczek I, Zou W, and Welling TH, Hepatology, 1/1/2015CD4+ T lymphocytes ablation prevents pancreatic carcinogenesis in mice
Zhang Y, Yan W, Esha M, Bednar F, Wan S, Collins MA, Evans RA, Welling TH, Vonderheide RH, Pasca di Magliano, M, Cancer Immunol Res, 1/1/2014Neoadjuvant stereotactic body radiation therapy (SBRT), capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma
Welling TH, Feng M, Wan S, Hwang, SY, Volk ML, Lawrence TS, Zalupski MM, Sonnenday CJ, Liver Transpl, 1/1/2014Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73)
Snider NT, Altshuler PJ, Wan S, Welling TH, Cavalcoli JD, Omary MB, Mol Biol Cell, 1/1/2014Heterogeneity of the CD90+ population in different stages of hepatocarcinogenesis
Smathorn T, Zhu J, Qixing L, Welling TH, Zhang M, Lubman DM, J Proteomics Bioinform, 1/1/2014T cells and co-stimulation in cancer
Maj T, Wei S, Welling TH, and Zou W, Cancer J, 1/1/2013Elevated serum IL-8 is associated with presence of hepatocellular carcinoma and independently predicts survival
Welling TH, Fu S, Wan S, Zou W, and Marrero JA, Cancer Invest, 1/1/2012The effect of smoking on biliary complications following liver transplantation
Mathur AK, Ranney DN, Patel SP, Lee DS, Bednar F, Lynch RJ, Welling TH, and Englesbe, MJ, Transplant Int, 1/1/2011The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre
Singal AG, Rakoski M, Salgia R, Pelletier S, Welling TH, Fontana RJ, Lok AS, Marrero JA, Aliment Pharmacol Ther, 1/1/2010Portal vein thrombosis and survival in patients with cirrhosis
Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling TH, Punch JD, Lynch RJ, Marrero JA, Pelletier SJ, Liver Transpl, 1/1/2010Phenotype, distribution, generation, functional and clinical relevance of Th17 cells in the human tumor environments
Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone DM, Welling TH, Chang A, Coukos G, Liu R, Zou W, Blood, 1/1/2009FOXP3 defines regulatory T cells in human tumor and autoimmune disease
Kryczek I, Liu R, Wang G, Wu K, Shu X, Szeliga W, Vatan L, Finlayson E, Huang E, Simeone DM, Redman B, Welling TH, Chang A, Zou W, Cancer Res., 1/1/2009Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/PD-1 interactions
Wu K, Kryczek I, Chen L, Zou W, Welling TH, Cancer Res., 1/1/2009Role of liver transplantation in the treatment of cholangiocarcinoma
Singal A, Welling TH, Marrero JA, Expert Rev Anticancer Ther, 1/1/2009Modern Diagnosis and Management of Hepatocellular Carcinoma
Marrero JA, Welling TH, Clinics in Liver Dis, 1/1/2009- Join now to see all